Amanda Robinson Kirane, M.D., F.A.C.S. for UC Davis Health

Amanda Robinson Kirane, M.D., F.A.C.S.

Assistant Professor, Department of Surgery

To see if Amanda Robinson Kirane is accepting new patients, or for assistance finding a UC Davis doctor, please call 800-2-UCDAVIS (800-282-3284).




Surgery - Oncology

Skin Cancer and Melanoma

Minimally Invasive Surgery

Robotic Surgery



Locations and Contact

2279 45th Street
Sacramento, CA 95817

Get Directions

Additional Numbers

Clinic Fax


Clinic Referral Phone


Physician Referrals

800-4-UCDAVIS (800-482-3284)

Philosophy of Care

Dr. Kirane aims to provide compassionate care as a partnership with her patients and their families with respect to each patient's individual needs. In complex cases, a multi-disciplinary team of specialists within the cancer center will collaboratively coordinate in effort to help guide our patients in decision making to ensure the highest quality care.

Clinical Interests

Dr. Kirane is a fellowship trained Complex General Surgical Oncologist with specialty training in Melanoma, other skin cancers, and soft tissue diseases as well as minimally invasive approaches to oncologic surgery in soft tissue, gastric, and hepatobiliary cancers.

Her clinical interests include regional therapies for locally advanced soft tissue cancers, including isolated limb infusion, as well as evolving technologies and therapies in advanced melanoma cases. She passionately believes in personalized medicine using evidence-based best practice to tailor treatment to each individual patient.

Research/Academic Interests

Dr. Kirane's academic interests include basic and translational science research in melanoma and sarcoma with specific interest in mechanisms of evasive resistance, tumor microenvironment signaling and immune response. Being able to move from bench to bedside and return allows for the rapid adaptation of surgical science to improved patient care.  

Her previous bench work has resulted in multiple ongoing trials of novel therapeutic strategies in pancreatic cancer. She is also invested in surgical education and clinical trials for novel targets in resistant melanoma.


Surgical Oncology

Center/Program Affiliation

UC Davis Comprehensive Cancer Center
UC Davis Medical Group

Undergraduate School

B.A., University of Texas, Austin TX 2002

Medical School

M.D., University of Texas Southwestern Medical School, Dallas TX 2006


General Surgery, Southwestern Medical Center, Dallas TX 2006-2007


General Surgery, Southwestern Medical Center, Dallas TX 2007-2009, 2012-2014


Physician-Scientist in Oncology, Hamon Center for Therapeutic Oncology Research, Dallas TX 2009-2012


Complex General Surgical Oncology, Memorial Sloan Kettering Cancer Center, New York NY 2014-2016

Women In Cancer Immunotherapy Network Leadership Institute, Society for Immunotherapy of Cancer, 2019

Innovation in Physician Wellness Award, UC Davis, 2019

Mentorship Academy Innovation Award, UC Davis, 2019

European Society of Medical Oncology Immunotherapy Correspondent, Society for Immunotherapy of Cancer, 2019

Best Oral Presentation �When is palliative surgery indicated in gastric Cancer? A Systematic Meta-analysis,� UC Davis Department of Surgery Research Symposium, 2018

Melanoma Bridge 2016 Travel Award, Society for Immunotherapy of Cancer, 2016

Award of Courage Fellow, Memorial Sloan Kettering Cancer Center, 2015

Society of Surgical Oncology, Best Basic/Translational Science Award, 2015

Wang E, Kao J, Ma C, Cheng MY, Barton VR, Petukhova TA, Kiuru M, Maverakis E, Kirane AR. Non-surgical management of primary invasive melanoma. J Dermatolog Treat. 2019 Nov 20;1-4. doi:10.1080/09546634.2019.1687830. Online ahead of print.

Judge SJ, Lata-Arias K, Yanagisawa M, Darrow MA, Monjazeb AM, Kirane AR, Bold RJ, Canter RJ, Canter DJ. Morbidity, mortality and temporal trends in the surgical management of retroperitoneal sarcoma: An ACS-NSQIP follow up analysis. J Surg Oncol. 2019 Sep;120(4):753-760. doi:10.1002/jso.25649. Epub 2019 Jul 29.

Bateni SB, Gingrich AA, Jeon SY, Hoch JS, Thorpe SW, Kirane AR, Bold RJ, Canter RJ. Clinical Outcomes and Costs Following Unplanned Excisions of Soft Tissue Sarcomas in the Elderly. J Surg Res. 2019 Jul;239:125-135. doi:10.1016/j.jss.2019.01.055. Epub 2019 Feb 27.

Gingrich AA, Bateni SB, Kirane AR, Bold RJ, Thorpe SW, Canter RJ. Extremity Soft Tissue Sarcoma in the Elderly: Are We Overtreating or Undertreating this Potentially Vulnerable Patient Population? J Surg Oncol. 2019 Jun;119(8):1087-1098. doi: 10.1002/jso.25470. Epub 2019 Apr 12.

Cassidy MR, Lefkowitz RA, Long N, Qin LX, Kirane A, Sbaity E, Hameed M, Coit DG, Brennan MF, Singer S, Crago AM. Association of MRI T2 Signal Intensity With Desmoid Tumor Progression During Active Observation: A Retrospective Cohort Study. Ann Surg. 2020 May 9:10.1097/SLA.0000000000003073. Published online 2018 Nov 9. doi:10.1097/SLA.0000000000003073.

Saiz AM Jr, Gingrich AA, Canter RJ, Kirane AR, Monjazeb AM, Randall RL, Thorpe SW. Role of Radiation Therapy in Adult Extraskeletal Ewing's Sarcoma Patients Treated with Chemotherapy and Surgery. Sarcoma. 2019 Apr 24;2019:5413527. doi:10.1155/2019/5413527. eCollection 2019

de la Torre J, Banerjee S, Baumgartner J, Lin GY, Burgoyne AM, Kirane A, Sicklick J. Tumor Symbiosis: Gastrointestinal Stromal Tumor as a Host for Primary Peritoneal Mesothelioma. J Gastrointest Surg. 2019 Apr;23(4):879-881. doi: 10.1007/s11605-018-3918-3. Epub 2018 Aug 21.

Kirane A, Zhang Y, Huang H, Sorrelle NB, Burrows FJ, Dellinger MT, Brekken RA. Cyclooxygenase-2 Inhibition Potentiates the Efficacy of Vascular Endothelial Growth Factor Blockade and Promotes an Immune Stimulatory Microenvironment in Preclinical Models of Pancreatic Cancer. Mol Cancer Res. 2019 Feb;17(2):348-355. doi:10.1158/1541-7786.MCR-18-0427. Epub 2018 Oct 17.

Ogawa H, Luxardi G, Kirane A, Kulkarni R, Monjazeb AM, Cheng MY, Ma C, Maverakis E. T Cells Dominate the Local Immune Response Induced by Intralesional IL-2 in Combination with Imiquimod and Retinoid for In-Transit Metastatic Melanoma. J Invest Dermatol. 2018 Jun;138(6):1442-1445. doi:10.1016/j.jid.2017.12.027. Epub 2017 Dec 29.

Yanagisawa M, Gingrich AA, Judge S, Li CS, Wang N, Thorpe SW, Kirane AR, Bold RJ, Monjazeb AM, Canter RJ. Serum C-reactive Protein and Neutrophil/Lymphocyte Ratio After Neoadjuvant Radiotherapy in Soft Tissue Sarcoma. Anticancer Res. 2018 Mar;38(3):1491-1497. doi:10.21873/anticanres.12376.